Anil Okay

ANIL OKAY is a Partner at Aztiq, an investment firm focused on healthcare and pharmaceutical sectors founded by Robert Wessman. Additionally, Anil serves as Chairman of the Board at Arphio, a rare disease pharmaceutical company, and as a Board Member at Newbury Pharmaceuticals AB, a specialty pharma platform. Anil is also the CEO & Board Member at Adalvo, working to build it as Europe's leading B2B pharma platform, and serves as the Chief Commercial Officer at Alvotech. Previously, Anil held various high-level positions at Alvogen and HELM AG, showcasing a strong background in business development within the pharmaceutical industry. Anil has also undergone executive education at renowned institutions such as Harvard Business School and INSEAD.